FSFatimata Bintou Sall

Fatimata Bintou Sall

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fatimata Bintou Sall has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rôle des virus EBV et VIH dans la formation de la translocation chromosomique t(8;14) du Lymphome de Burkitt

    by Fatimata Bintou Sall

    Le Lymphome de Burkitt est un lymphome non hodgkinien de type B caractérisé dans 80% des cas par une translocation chromosomique impliquant l’oncogène MYC sur le chromosome 8 et le gène des chaines lourdes d’immunoglobuline IGH sur le chromosome 14. Le développement de ce lymphome est étroitement lié au virus EBV, systématiquement présent dans les formes endémiques et au VIH qui lui définit une entité clinique à part. Cependant, le rôle joué par ces virus dans la formation de la translocation est peu connu. Des cassures double brins simultanées, une réparation non-homologue de ces cassures et une proximité spatiale sont les conditions nécessaires pour que deux loci forment une translocation. Nous avons ainsi investigué l’effet des virus EBV sur ces trois conditions dans les lymphocytes B. Nos résultats montrent que la réactivation du virus EBV dans les lymphocytes B infectées de façon latente augmente la proximité spatiale entre MYC et IGH, normalement situés dans des compartiments différents. Cette relocalisation semble être secondaire à l’induction de dommages d’ADN spécifiques sur MYC et serait médiée par la protéine de réparation de l’ADN MRE11. Nous montrons aussi que la protéine Tat du VIH-1 peut pénétrer dans les cellules B et y induire une expression aberrante du gène AICDA qui peut secondairement introduire des cassures doubles brins simultanées sur MYC et IGH. Ce travail fournit une preuve de l’implication directe du cycle lytique d’EBV dans la formation de la t(8;14) et renforce les données existantes sur le rôle de Tat dans cette translocation.

  • Open Access

    Evaluating Treatment and Safety Outcomes of a Shorter Regimen for Drug-Resistant TB in Nigeria: An Implementation Research Study

    by Victor Babawale, Clement Adesigbin, Corinne S. Merle, Vanessa Veronese, Fatimata Bintou Sall, Benjamin Seydou Sombie, Eunice Nnaisa Jiya-Chitumu, Chizaram Onyeaghala, Adegboyega Moses Oyefabi, Rotimi Samuel Owolabi, et al.

    The introduction of significantly shorter, all-oral regimens has significantly shifted the management of drug-resistant tuberculosis (DR-TB) towards a more tolerable and patient-centred therapeutic approach that aims to enhance treatment adherence, clinical outcomes, and quality of life among patients. Nigeria has gradually adopted this all-oral, shorter regimen, but the impact of this regimen in programmatic settings has not yet been studied. In 2022, a longitudinal, two-armed cohort study was conducted to explore the effectiveness, safety, and feasibility of the all-oral shorter regimen in the programmatic management of RR/MDR-TB in Nigeria. Consenting and eligible RR/MDR-TB patients receiving the all-oral regimen (intervention group) in four states were consecutively enrolled and compared to those receiving the standard of care (SOC). Treatment effectiveness, proportion, and 95% confidence intervals of favourable and unfavourable outcomes were measured at the end of treatment and during follow-up (six and 12 months post-treatment). In total 383 Participants were followed monthly throughout the 9–12-month treatment phase and then reassessed at 6 and 12 months after treatment completion, giving a total possible observation period of up to 24 months (185 received the intervention and 198 the standard of care). At the end of follow-up, there was a higher but non-significant proportion of favourable outcomes among the intervention vs. SOC group (80% vs. 69.7%); a higher proportion of favourable outcomes was also noted at the end of treatment among intervention participants (81.1 vs. 76.8%). Around one third of patients reported at least one serious adverse event (SAE), with no significant differences between arms, and none were deemed related to the use of medication. Intervention participants reported greater improvements in health-related quality of life between baseline and four months compared to those receiving the SOC. These findings support the programmatic use of all-oral shorter treatment for RR/MDR-TB as a regimen that is effective, tolerable, safe, and associated with enhanced health-related quality of life for patients in Nigeria.

  • Open Access

    Oncogenic Properties of the EBV ZEBRA Protein

    by Diego Germini, Fatimata Bintou Sall, Anna Shmakova, Joëlle Wiels, Svetlana Dokudovskaya, Emmanuel Drouet, Yegor Vassetzky

    Epstein Barr Virus (EBV) is one of the most common human herpesviruses. After primary infection, it can persist in the host throughout their lifetime in a latent form, from which it can reactivate following specific stimuli. EBV reactivation is triggered by transcriptional transactivator proteins ZEBRA (also known as Z, EB-1, Zta or BZLF1) and RTA (also known as BRLF1). Here we discuss the structural and functional features of ZEBRA, its role in oncogenesis and its possible implication as a prognostic or diagnostic marker. Modulation of host gene expression by ZEBRA can deregulate the immune surveillance, allow the immune escape, and favor tumor progression. It also interacts with host proteins, thereby modifying their functions. ZEBRA is released into the bloodstream by infected cells and can potentially penetrate any cell through its cell-penetrating domain; therefore, it can also change the fate of non-infected cells. The features of ZEBRA described in this review outline its importance in EBV-related malignancies.


  • Open Access

    Large-scale nuclear remodeling and transcriptional deregulation occur on both derivative chromosomes after Mantle Cell Lymphoma chromosomal translocation

    by Fatimata Bintou Sall, Andrei Pichugin, Olga Iarovaia, Ana Barat, Tatyana Tsfasman, Caroline Brossas, Marie-Noëlle Prioleau, Eugeny V. Sheval, Anastasiya A. Zharikova, Julien Lazarovici, et al.

    Recurrent chromosomal translocations are found in many blood and solid cancers. Balanced translocations, frequent in lymphoid malignancies, lead to the formation of two aberrant derivative (der) chromosomes. This event often leads to overexpression of an oncogene. In many cases, the expression of an oncogene is not enough to produce a malignant phenotype; however, most part of the studies focus on the events involving the chromosome where the oncogene is located, but rarely the other der chromosome where other oncogenic alterations may potentially arise. Mantle cell lymphoma (MCL), an aggressive B-cell non-Hodgkin lymphoma, is a perfect example of this. In 85% of the cases, it is characterized by the translocation t(11;14), which leads to the overexpression of cyclin D1 (CCND1) gene which results juxtaposed to the immunoglobulin heavy chain (IGH) gene on the der14 chromosome. This feature alone is not sufficient to induce oncogenesis. Here we focused on the der11 chromosome. We demonstrated that expression of 88 genes located in a 15mb region close to the translocation breakpoint on the der11 was deregulated both in the GRANTA-519 MCL cell line and in B-cells from MCL patients. We found that a large segment of der11containing deregulated genes was relocated from its normal position in the nuclear periphery towards the center of the nucleus in close proximity to the nucleolus where the abundant nucleolar protein nucleolin binds a subset of genes located close to the breakpoint and activates their expression. This finding allowed to identify new potential oncogenes involved in MCL and the mechanisms of their upregulation.


  • HIV‐1 Tat protein induces aberrant activation of AICDA in human B‐lymphocytes from peripheral blood

    by Fatimata Bintou Sall, Rawan El Amine, Diana Markozashvili, Tatyana Tsfasman, Eric Oksenhendler, Marc Lipinski, Yegor Vassetzky, Diego Germini

    Individuals infected with human immunodeficiency virus (HIV) are at increased risk for Burkitt lymphoma, a B‐cell malignancy which occurs after a chromosomal translocation rearranging the MYC oncogene with an immunoglobulin gene locus, usually the IGH heavy chain gene locus. We have previously reported that the HIV protein Tat which circulates in all HIV‐positive individuals whatever their immune status caused an increased rate of colocalization between IGH and MYC in B‐cells nuclei. We here present in vitro evidence that Tat activates the expression of the AICDA gene that encodes the activation‐induced cytidine deaminase whose physiological function is to create double‐strand breaks for immunoglobulin gene maturation. In the presence of Tat, DNA damage was observed concomitantly in both MYC and IGH, followed by DNA repair by nonhomologous end joining. AICDA was further found overexpressed in vivo in peripheral blood B‐cells from HIV‐infected individuals. Thus, the capacity of Tat to spontaneously penetrate B‐cells could be sufficient to favor the occurrence of MYC‐IGH oncogenic rearrangements during erroneous repair, a plausible cause for the increased incidence of Burkitt lymphoma in the HIV‐infected population.


  • Effect of Environmental Factors on Nuclear Organization and Transformation of Human B Lymphocytes

    by F. B. Sall, D. Germini, A. P. Kovina, V. Ribrag, J. Wiels, A. O. Toure, O. V. Iarovaia, M. Lipinski, Y. Vassetzky

    Chromosomal translocations have long been known for their association with malignant transformation, particularly in hematopoietic disorders such as B-cell lymphomas. In addition to the physiological...


  • Open Access

    Characteristics of chronic lymphocytic leukemia in Senegal

    by Abibatou Sall, Awa Oumar Touré, Fatimata Bintou Sall, Moussa Ndour, Seynabou Fall, Abdoulaye Sène, Blaise Félix Faye, Moussa Seck, Macoura Gadji, Tandakha Ndiaye Dièye, et al.

    Chronic lymphocytic leukemia (CLL) is a mature B-cell neoplasm characterized by the expansion of CD5-positive lymphocytes in peripheral blood. While CLL is the most common type of leukemia in Western populations, the disease is rare in Africans. Hence, clinical and laboratory data and studies of CLL in Sub Saharan populations have been limited. The aims of this study were to analyze the characteristics of senegalese patients with CLL at the time of the diagnosis and to identify the correlation between clinical characteristics (Binet stage) with age, gender, laboratory parameters and chromosomal abnormalities. In this study, we investigated the clinical and laboratory characteristics of CLL in Senegal. A total of 40 patients who had been diagnosed with CLL during the period from July 2011 to April 2015 in Senegal were evaluated. Cytology and immunophenotype were performed in all patients to confirm the diagnosis. The prognosis factors such as Binet staging, CD38 and cytogenetic abnormalities were studied. The statistical analysis was performed using STATA version 13 (Stata college station Texas). Each patient signed a free and informed consent form before participating in the study. The mean age was 61 years ranged from 48 to 85. There were 31 males and only 9 females (sex ratio M : F = 3,44). At diagnosic, 82.5 % of the patients were classified as having advanced Binet stages B or C. The prognosis marker CD38 was positive in 28 patients. Cytogenetic abnormalities studied by FISH were performed in 25 patients, among them, 68 % (17 cases) had at least one cytogenetic abnormality and 28 % had 2 simultaneous cytogenetic abnormalities. Africans may present with CLL at a younger age and our data suggest that CLL in Senegal may be more aggressive than in Western populations.


  • Syndrome d’hémophagocytose et leucémie aiguë myéloblastique

    by A. Sall, F.B. Akondé, F.B. Sall, M.N. Diouf, A. Sène, B.F. Faye, M. Gadji, M. Seck, A.O. Touré, S. Diop

  • Open Access

    Rosai Dorfman disease diagnosed by fine‐needle aspiration cytology in a young man with HIV infection

    by Abibatou Sall, Awa Oumar Touré, Fatou Samba Ndiaye, Abdoulaye Sène, Fatimata Bintou Sall, Blaise Félix Faye, Moussa Seck, Saliou Diop

    RDD (Rosai Dorfman disease) is a rare and benign histiocytic proliferative disorder of unknown etiology. FNAC (Fine‐needle aspiration cytology) is a useful and reliable tool for the diagnosis of RDD, and as such, biopsy is avoidable.